Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2023, 'Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis', Melanoma Research, 33, pp. 316 - 325, http://dx.doi.org/10.1097/CMR.0000000000000900
, 2023, 'Chemotherapy in Cutaneous Melanoma: Is There Still a Role?', Current Oncology Reports, 25, pp. 609 - 621, http://dx.doi.org/10.1007/s11912-023-01385-6
, 2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605
, 2023, 'Academic dermatology in Australia and New Zealand between 2017 and 2022: A cross-sectional bibliometric analysis', Australasian Journal of Dermatology, 64, pp. 213 - 220, http://dx.doi.org/10.1111/ajd.14025
, 2023, 'Re: ‘The impact of systemic psoriasis treatments on human papillomavirus activation and propagation’—What about anal malignancies?', Australasian Journal of Dermatology, 64, pp. e204 - e206, http://dx.doi.org/10.1111/ajd.14009
, 2023, 'Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis', Journal of the European Academy of Dermatology and Venereology, 37, pp. e363 - e365, http://dx.doi.org/10.1111/jdv.18649
, 2023, '1127P Efficacy of immune checkpoint inhibitors (ICIs) in advanced mucosal melanoma (MM): A systematic review and meta-analysis', Annals of Oncology, 34, pp. s677, http://dx.doi.org/10.1016/j.annonc.2023.09.2261
, 2023, 'The nutritional impact of CD19‐targeted CAR‐T therapy versus BEAM chemotherapy for adult patients with lymphoma', Journal of Human Nutrition and Dietetics, 36, pp. 2099 - 2107, http://dx.doi.org/10.1111/jhn.13210
, 2022, 'Morbilliform eruption and systemic inflammatory response syndrome following mRNA COVID-19 vaccination in a patient receiving penicillamine', International Journal of Women S Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000058
, 2022, 'Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series', Australasian Journal of Dermatology, 63, pp. 522 - 524, http://dx.doi.org/10.1111/ajd.13925
, 2022, 'BRAF inhibition and the spectrum of granulomatous reactions', Journal of the American Academy of Dermatology, 87, pp. 605 - 613, http://dx.doi.org/10.1016/j.jaad.2021.10.030
, 2022, 'Severe disseminated primary varicella in a patient on long term inhaled corticosteroids', Respirology Case Reports, 10, http://dx.doi.org/10.1002/rcr2.1010
, 2022, 'A review of the cutaneous toxicities of tebentafusp—Featuring two cases involving superficial bullous reactions', Australasian Journal of Dermatology, 63, pp. e279 - e282, http://dx.doi.org/10.1111/ajd.13866
, 2022, 'Acute generalised exanthematous pustulosis and cutaneous vasculitis: Not always just pustules?', Australasian Journal of Dermatology, 63, pp. 136 - 139, http://dx.doi.org/10.1111/ajd.13776
, 2021, 'Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor', Skin Health and Disease, 1, http://dx.doi.org/10.1002/ski2.71
, 2021, 'Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis', Journal of Dermatology, 48, pp. 1619 - 1621, http://dx.doi.org/10.1111/1346-8138.16073
, 2016, 'Open source drug discovery: Highly potent antimalarial compounds derived from the tres cantos arylpyrroles', ACS Central Science, 2, pp. 687 - 701, http://dx.doi.org/10.1021/acscentsci.6b00086
, 2010, 'NOX Reduction Strategy', POWER ENGINEERING, 114, pp. 46 - +
Conference Papers
, 2025, 'DDDR-54. Mitochondrial Protease LonP1 Drives Resistance to Proteasome Inhibitors in Glioblastoma and Offers a Novel Therapeutic Target', in Neuro-Oncology, Oxford University Press (OUP), pp. v175 - v175, http://dx.doi.org/10.1093/neuonc/noaf201.0691
, 2025, 'Gender Influences Clinical Response to Guselkumab in Hidradenitis Suppurativa: A post-hoc analysis of Phase 2 Individual Patient Data', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, FL, Orlando, presented at Annual Meeting of the American-Academy-of-Dermatology (AAD), FL, Orlando, 07 March 2025 - 11 March 2025
, 2025, 'The Clinical and Molecular Response of Pyoderma Gangrenosum to Interleukin 23 Blockade: Result from a proof-of-concept open-label clinical trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB313 - AB313
, 2024, 'Abstract 4731: Targeting Lon protease as novel strategy to treat aggressive IDH mutant diffuse malignant astrocytoma', in Cancer Research, American Association for Cancer Research (AACR), pp. 4731 - 4731, http://dx.doi.org/10.1158/1538-7445.am2024-4731
, 2023, 'Lower limb pigmentation: Relative contribution of haemosiderin and melanin in chronic venous disease and other cutaneous disorders', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 107 - 107
, 2023, 'Resident cutaneous memory T-cells: A review of their role in modulating chronic inflammatory dermatoses and potential as therapeutic targets', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 80 - 81
, 2022, 'Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’', in Journal of the European Academy of Dermatology and Venereology, pp. e1004 - e1006, http://dx.doi.org/10.1111/jdv.18403
, 2022, 'Pathology/
, 2013, 'Shaped Charge Jet Characterization and Initiation Test Configuration for IM Threat Testing', in Procedia Engineering, Elsevier, pp. 58 - 67, http://dx.doi.org/10.1016/j.proeng.2013.05.009
Conference Abstracts
, 2026, 'Exploring the role of LONP1 in lon-traditional mechanisms of glioblastoma resistance.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 86, presented at AACR Annual Meeting, CA, San Diego, 17 April 2026 - 22 April 2026, http://dx.doi.org/10.1158/1538-7445.AM2026-382
, 2024, 'A meta-analysis of overall survival and response in metastatic adrenocortical carcinoma: A review of 23 prospective trials of 880 patients.', in Journal of Clinical Oncology, Vol. 42, pp. 4 - 4, http://dx.doi.org/10.1200/JCO.2024.42.4_suppl.4
, 2022, 'BRAF inhibition and the spectrum of Granulomatous Reactions', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 106 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'If your ears are burning we must be talking about Red Ear Syndrome: A case report', in Australasian Journal of Dermatology, Wiley, Vol. 63, pp. e244 - e246, presented at Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.13862
, 2022, 'Morbiliform eruption and Systemic Inflammatory Response Syndrome following COVID-19 mRNA vaccination', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1